| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 43,565 | 164,202 | 108,003 | 47,239 | | Cost of Revenue | 11,685 |
-
| 8,154 | (12,541) | | | Gross Profit | 31,880 | 164,202 | 99,849 | 59,780 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,174 | 19,639 | 11,588 | 28,423 | | Non Recurring | (139,585) |
-
|
-
| (20,465) | | Others | 6,270 | 123,860 | 166,882 | 4,548 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (52,046) | 20,703 | (78,621) | 47,274 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 163,334 | (64,239) | (613,179) | (323,788) | | Earnings Before Interest And Taxes | 207,707 | (43,543) | (502,220) | (178,111) | | Interest Expense | 230,206 | 103,020 |
-
|
-
| | Income Before Tax | (22,499) | (146,563) | (502,220) | (178,111) | | Income Tax Expense | (216) | (36) | 124 | 173 | | Minority Interest | 7,324 |
-
| 189,580 | 99,347 | | | | Net Income From Continuing Ops | (27,859) | (146,527) | (502,344) | (178,284) | | | Non-recurring Events | | Discontinued Operations | 494 | (1,887) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (27,365) | (148,414) | (502,344) | (178,284) | | Preferred Stock And Other Adjustments |
-
| 4,182 | (3,414) | (3,406) | | | Net Income Applicable To Common Shares | ($24,692) | ($144,232) | ($505,758) | ($181,690) |
|
0.50% Nasdaq 0.00%
Income Statement
